Navan Inc. Class A Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Navan Inc. Class A Common Stock trades at $23.63 (market cap $6.01B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 6.7× Navan Inc. Class A Common Stock's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Navan Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Navan Inc. Class A Common Stock for 1 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| NAVN | RVMD | |
|---|---|---|
Market Cap | $6.01B | $40.32B |
Volume | 2,990,425 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $30.58 | $221.15 |
52-Week Low | $8.51 | $47.50 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $5.36B | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.
Read more on NAVN →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →